Date to be announced
Contact us for more infoTRAINING TIMES
Understand industry approaches for Scale-up, Technology Transfer, and PV applying QbD principles
Gain regulatory insights & guidance on how to realize Technology Transfers and PV
Explore proven best practices in Scale-up for solid dose manufacturing processes
Gain practical knowledge and tools during two interactive sessions and workshops
Take an excellent opportunity to discuss issues & challenges with industry peers and with an expert
Boehringer Ingelheim Pharma, Director Late Stage Drug Product Development
Dr. Braun is a trained pharmacist with 20 years of experience in Drug Product Development. He received his Ph.D. in Pharmaceutical Technology at the University of Bonn and started his career in the pharmaceutical industry as Head of Pharmaceutical Development at Rentschler Pharma. In 2006, Michael joined Boehringer Ingelheim and worked in different positions with increasing responsibility within Pharmaceutical Development and R&D Project Management. Since 2014, he is Director Late Stage Drug Product Development and responsible for process development and scale-up of solid and liquid orals, parenterals and inhalative NCE products. This also includes product transfers to operations, launch support and preparation of submission documentation.
Learn More →
Take a sneak peek at the trainer's presentation.
View PDF →